PubMed (GeneRIF) for id: 5601

Year	Number of Results
2002	2
2003	2
2004	4
2005	6
2006	4
2007	6
2008	9
2009	16
2010	11
2011	7
2012	8
2013	9
2014	13
2015	6
2016	5
2017	4
2018	7
2019	3
2021	4
2022	1
2023	1
2024	0

1

JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma via Inhibiting Axin2.

Wang L, Guo M, Gao L, Liu K, Bai J, Liu Z. Wang L, et al. Curr Pharm Des. 2023;29(37):2977-2987. doi: 10.2174/0113816128261624231030110157. Curr Pharm Des. 2023. PMID: 37957865

2

c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease.

Smith AO, Jonassen JA, Preval KM, Davis RJ, Pazour GJ. Smith AO, et al. PLoS Genet. 2021 Dec 28;17(12):e1009711. doi: 10.1371/journal.pgen.1009711. eCollection 2021 Dec. PLoS Genet. 2021. PMID: 34962918 Free PMC article.

3

miR-221-5p-Mediated Downregulation of JNK2 Aggravates Acute Lung Injury.

Yang J, Do-Umehara HC, Zhang Q, Wang H, Hou C, Dong H, Perez EA, Sala MA, Anekalla KR, Walter JM, Liu S, Wunderink RG, Budinger GRS, Liu J. Yang J, et al. Front Immunol. 2021 Nov 25;12:700933. doi: 10.3389/fimmu.2021.700933. eCollection 2021. Front Immunol. 2021. PMID: 34899681 Free PMC article.

4

The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases.

Chen J, Ye C, Wan C, Li G, Peng L, Peng Y, Fang R. Chen J, et al. Int J Mol Sci. 2021 Sep 6;22(17):9640. doi: 10.3390/ijms22179640. Int J Mol Sci. 2021. PMID: 34502556 Free PMC article. Review.

5

c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1.

Tian X, Traub B, Shi J, Huber N, Schreiner S, Chen G, Zhou S, Henne-Bruns D, Knippschild U, Kornmann M. Tian X, et al. Cancer Gene Ther. 2022 Jan;29(1):73-86. doi: 10.1038/s41417-020-00290-5. Epub 2021 Feb 1. Cancer Gene Ther. 2022. PMID: 33526844 Free PMC article.

6

Polymorphisms in MAPK9 (rs4147385) and CSF1R (rs17725712) are associated with the development of inhibitors in patients with haemophilia A in North China.

Zhao M, Zhang Y, Liu Y, Sun G, Tian H, Hong L. Zhao M, et al. Int J Lab Hematol. 2019 Aug;41(4):572-577. doi: 10.1111/ijlh.13055. Epub 2019 May 31. Int J Lab Hematol. 2019. PMID: 31149782 Clinical Trial.

7

JNK^1/2 represses Lkb¹-deficiency-induced lung squamous cell carcinoma progression.

Liu J, Wang T, Creighton CJ, Wu SP, Ray M, Janardhan KS, Willson CJ, Cho SN, Castro PD, Ittmann MM, Li JL, Davis RJ, DeMayo FJ. Liu J, et al. Nat Commun. 2019 May 14;10(1):2148. doi: 10.1038/s41467-019-09843-1. Nat Commun. 2019. PMID: 31089135 Free PMC article.

8

JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells.

Du L, Anderson A, Nguyen K, Ojeda SS, Ortiz-Rivera I, Nguyen TN, Zhang T, Kaoud TS, Gray NS, Dalby KN, Tsai KY. Du L, et al. ACS Chem Biol. 2019 Jul 19;14(7):1426-1435. doi: 10.1021/acschembio.9b00083. Epub 2019 May 17. ACS Chem Biol. 2019. PMID: 31063355 Free PMC article.

9

[Overexpression of JNK2 enhances proliferation and anti-apoptotic ability of SCL-1 human cutaneous squamous cell carcinoma cells].

Liu H, Dong H, Zhang X, Chen Y, Jiao Y, Ge X. Liu H, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 Nov;34(11):1000-1007. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018. PMID: 30591109 Chinese.

10

H₂O₂ oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes.

Nelson KJ, Bolduc JA, Wu H, Collins JA, Burke EA, Reisz JA, Klomsiri C, Wood ST, Yammani RR, Poole LB, Furdui CM, Loeser RF. Nelson KJ, et al. J Biol Chem. 2018 Oct 19;293(42):16376-16389. doi: 10.1074/jbc.RA118.004613. Epub 2018 Sep 6. J Biol Chem. 2018. PMID: 30190325 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year